Rinvoq ER 45 MG tablet UU 28S

Ended Awarded

Contract number
SPE2DB23FC2Q3
Awardee
Awarding agency
Obligated
$10,804

Award facts

Contract value 100% obligated
$10,804.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to Amerisourcebergen Drug Corporation for $10,804.42 to supply 4561326514 RINVOQ ER 45 MG tablets. Performance will take place in Conshohocken, Pennsylvania from June 23 to June 26, 2023. The firm-fixed-price order is for the delivery of RINVOQ, an oral Janus kinase inhibitor medication used to treat rheumatoid arthritis. As a major provider of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order supports the Defense Logistics Agency's mission to provide crucial medical resources to military personnel and their families.

Quick answers

Who was awarded contract SPE2DB23FC2Q3?

SPE2DB23FC2Q3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 23, 2023.

How much is contract SPE2DB23FC2Q3 worth?

The government has obligated $10,804 on SPE2DB23FC2Q3.

Is contract SPE2DB23FC2Q3 an order under another contract?

Yes. SPE2DB23FC2Q3 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.

Was contract SPE2DB23FC2Q3 competed?

The extent of competition for SPE2DB23FC2Q3 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award